Tokyo Tape
Sign in
5% STAKE4883.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Modalis Therapeutics to 30.25%

Stake history

0%10%20%30%40%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC10.84%Jul 31Jul 31: 10.84% · S100U4O97.74%Aug 16Aug 16: 7.74% · S100U8RP6.26%Aug 19Aug 19: 6.26% · S100U8X26.54%Aug 20Aug 20: 6.54% · S100U93J5.42%Aug 28Aug 28: 5.42% · S100UABN31.76%Aug 30Aug 30: 31.76% · S100UAIR30.25%Sep 2Sep 2: 30.25% · S100UB4P
0%10%20%30%40%15.95%PriorPrior: 15.95% · prior ratio stated in S100U2AC11.95%Jul 19Jul 19: 11.95% · S100U2AC10.84%Jul 31Jul 31: 10.84% · S100U4O97.74%Aug 16Aug 16: 7.74% · S100U8RP6.26%Aug 19Aug 19: 6.26% · S100U8X26.54%Aug 20Aug 20: 6.54% · S100U93J5.42%Aug 28Aug 28: 5.42% · S100UABN31.76%Aug 30Aug 30: 31.76% · S100UAIR30.25%Sep 2Sep 2: 30.25% · S100UB4P

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-09-02 12:05 JST concerning Modalis Therapeutics Corporation. Reported holding ratio: 30.25%, previous report: 31.76%.

Stock price4883 · View chart ↗

Open the price chart on TradingView.

Source: EDINET S100UB4P ↗ · PDL1.0 · Not investment advice